Skip to content

the Prognosis of Fetoscopy Treatment of Twin Transfusion Syndrome

the Prognosis of Fetoscopy Treatment of Twin Transfusion Syndrome in Shengjing Hospital

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04952415
Enrollment
100
Registered
2021-07-07
Start date
2021-07-01
Completion date
2026-07-01
Last updated
2021-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Twin Diseases

Keywords

TTTS

Brief summary

Fetal medicine in China is still a new, young discipline, and the development is very rapid. After nearly 10 years of development, the clinical diagnosis and treatment guidelines of some complicated twin diseases has been established. Among them, twin-to-twin-transfusion syndrome (TTTS) is serious disease in twin pregnancy, and the factors affecting prognosis after fetoscopic laser surgery are part of the study. Through this study, the investigators expect to achieve better prediction indicators of the prognosis of TTTS.

Detailed description

A better guideline for twin-to-twin-transfusion syndrome are anticipated to be established in China. Fetoscopic laser surgery is applied to treat TTTS. After surgery, better prediction indicators of the prognosis of TTTS are needed.

Interventions

None listed

Sponsors

Shengjing Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

TTTS after fetoscopic laser surgery.

Exclusion criteria

Pregnant women who refuse to take part in the study

Design outcomes

Primary

MeasureTime frameDescription
Weight in kilogram of neonateAt birth of neonateIncluding twin pregnancy of TTTS after fetoscopic laser surgery measured by nurses

Secondary

MeasureTime frameDescription
Neurodevelopment at early childhoodAt age of 1 year oldIncluding adaptive, gross motor, fine motor, language, and social function; assessed using Gesell Developmental Schedules.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026